Effects of Two Training Protocols in Patients With Chronic Obstructive Pulmonary Disease

Overview

Introduction: There is evidence that demonstrate the beneficial effects of pulmonary rehabilitation programs (PR) on symptoms, exercise capacity, muscle strength and quality of life in patients with Chronic obstructive pulmonary disease (COPD). The majority of the studies used high intensity endurance and strength exercise training on land. Exercise on water is an effective form of training that has been used for decades for rehabilitation in different chronic conditions. In addition, there are promising preliminary results on the literature regarding aquatic training in patients with COPD. However, several gaps remain. Aim: Compare the effects of two rehabilitation programs with 6 months of duration in patients with COPD on physical activity in daily life and balance: land versus water. Methods: The sample will consist of 36 patients with COPD diagnosed according to the GOLD criteria, 50 years old or more and clinically stable. Patients will be evaluated in 3 different moments: before the PR, after the PR and 6 months after the end of the PR (follow up). In addition to the assessment of physical activity in daily life and balance, the investigators will also evaluate pulmonary function, peripheral and respiratory muscle strength, body composition, maximal and submaximal exercise capacity, functional status and quality of life. Both groups (land or water) will be submitted for 3 sessions of exercise training per week, with 45 minutes of duration, during 6 months. The sessions of both groups include the same exercises sequence. Endurance exercise training will be performed on a bicycle and walking on land and strength training using free weights. Workload will be established according to the tests performance on assessment and progression will follow a predetermined schedule and adjusted according symptoms. On water the same approach will be followed. Expected results: the investigators expect improvement in terms of symptoms, exercise capacity, muscle strength, quality of life, functional status and physical activity in daily life at the end of the two training protocols. However, it is unclear whether one training protocol will be superior than the other. Due to the characteristics involved in the aquatic training, the investigators hypothesized that this type of training can result in better results on balance.

Full Title of Study: “Effects of Two Training Protocols in Physical Activity in Daily Life and Balance in Patients With COPD: Land Versus Water”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: December 2014

Detailed Description

There is evidence that demonstrate the beneficial effects of pulmonary rehabilitation programs (PR) on symptoms, exercise capacity, muscle strength and quality of life in patients with Chronic obstructive pulmonary disease (COPD). The majority of the studies used high intensity endurance and strength exercise training on land. Exercise on water is an effective form of training that has been used for decades for rehabilitation in different chronic conditions. In addition, there are promising preliminary results on the literature regarding aquatic training in patients with COPD. However, several gaps remain. Therefore, we aim to compare the effects of two rehabilitation programs with 6 months of duration in patients with COPD on physical activity in daily life and balance: land versus water. The sample will consist of 36 patients with COPD diagnosed according to the GOLD criteria, 50 years old or more and clinically stable. Patients will be evaluated in 3 different moments: before the PR, after the PR and 6 months after the end of the PR (follow up). In addition to the assessment of physical activity in daily life and balance, the investigators will also evaluate pulmonary function, peripheral and respiratory muscle strength, body composition, maximal and submaximal exercise capacity, functional status and quality of life. Both groups (land or water) will be submitted for 3 sessions of exercise training per week, with 45 minutes of duration, during 6 months. The sessions of both groups include the same exercises sequence. Endurance exercise training will be performed on a bicycle and walking on land and strength training using free weights. Workload will be established according to the tests performance on assessment and progression will follow a predetermined schedule and adjusted according symptoms. On water the same approach will be followed. Expected results: the investigators expect improvement in terms of symptoms, exercise capacity, muscle strength, quality of life, functional status and physical activity in daily life at the end of the two training protocols. However, it is unclear whether one training protocol will be superior than the other. Due to the characteristics involved in the aquatic training, the investigators hypothesized that this type of training can result in better results on balance.

Interventions

  • Other: Exercise training
    • Comparison of high intensity exercise training on land versus water.

Arms, Groups and Cohorts

  • Other: Exercise training on land
    • High intensity exercise training on land.
  • Other: Exercise training on water
    • High intensity exercise training on water.

Clinical Trial Outcome Measures

Primary Measures

  • Physical activity in daily life (measuremet unit: number of steps per day)
    • Time Frame: four years
    • The objectively assessed level of physical activity in daily life will be monitored using the activity monitor Power Walker PW 610 (Yamax, Japan). This device is validated in patients with COPD and the main variables are the number of steps per day and estimation of daily energy expenditure. The monitor will be individually set taking into consideration body weight and step length (measured in a 10-meter walking at usual speed). Patients will wear the device 12 hours per day during 6 days, and the average of these six days will be used for analysis.

Secondary Measures

  • Static Balance (Center of Pressure Area in cm2)
    • Time Frame: four years
    • Static balance will be evaluated using a force platform (BIOMEC400, EMG System of Brazil, Brazil), which is a reliable instrument for stabilographic measures in both, older and young adults.
  • Dynamic Balance (Timed up and go test in seconds)
    • Time Frame: four years
    • Dynamic balance will be assessed by Timed up and go test (TUG).
  • Exercise capacity (6MWT: distance covered in meters; ISWT: distance covered in meters)
    • Time Frame: four years
    • The 6-minute walking test (6MWT) will be performed to verify functional exercise capacity and the Incremental shuttle walk test (ISWT) to assess maximal exercise capacity.
  • Quality of life (CRDQ: score in points)
    • Time Frame: four years
    • The Chronic Respiratory Disease Questionnaire (CRDQ) will be applied to assess quality of life.
  • Functional status (LCADL: score in points)
    • Time Frame: four years
    • Functional status will be assessed by using the questionnaire “London Chest Activity of Daily Living scale” (LCADL). A total score is calculated according to the patient report for each domain.

Participating in This Clinical Trial

Inclusion Criteria

  • COPD diagnosis (according to the GOLD criteria); – Stable condition, no exacerbations or infections in the last 3 months; – No severe or unstable heart disease; – No other pathological conditions that could influence the training performance; – Not have participated in other rehabilitation programs in the last six months. Exclusion Criteria:

  • Occurrence of acute exacerbation during the evaluation period; – Not understanding or non-cooperation regarding the procedures and research methods; – Option of the participant to leave the study for any reason; – Presence of vestibular disorders (BPPV, labyrinthitis, among others).

Gender Eligibility: All

Minimum Age: 50 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Universidade Norte do Paraná
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Fabio Pitta, PhD, Study Director, Universidade Estadual de Londrina
    • Vanessa S. Probst, PhD, Principal Investigator, Universidade Norte do Paraná

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.